ROLE OF II CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
ROLE OF II CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
批准号:
2069129
负责人:
VICTOR E. REYES
金额:
$10.5万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1999-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term objective of this project is to define the role of the
invariant chain (I-i) in antigen processing and presentation. To
approach this goal the following aims are proposed: (1) To define the
conditions that lead to cleavage and release of I-i from class II MHC
molecules; (2) To characterize the cleavage fragments generated during
the proteolytic events which lead to I-i release; (3) To identify the
region(s) within I-i which associate(s) with class II MHC or the antigen
binding site; and, (4) To determine whether peptide binding to class II
MHC molecules depends upon or is enhanced by the removal of I-i. To
address Aim 1, the proposed experiments are aimed at mimicking the
endosomal environment (low pH and/or the presence of specific proteases)
to induce I-i release from class II MHC as detected by
immunoprecipitation and SDS-PAGE analysis. As part of Aim 2, the
fragments generated during cleavage and release of I-i will be
characterized through Western blotting with antibodies to N-terminal
(VicY1) and C-terminal (E1) epitopes in I-i as well as rabbit antisera to
synthetic peptides corresponding to various regions within I-i. Partial
N-terminal sequencing of the fragments will be performed on fragments
isolated by either reverse phase HPLC or 2D electrophoresis and
electroblotting. In Aim 3, isolated I-i fragments which result following
cleavage and release of I-i from class II MHC molecules will be examined
for their ability to block peptide presentation presumably as a result of
binding to the antigen binding site on class II MHC molecules;. thus,
identifying the I-i sequence which blocks the desetope. Having
elucidated the conditions which lead to I-i removal, in Aim 4 those
conditions will be reproduced in the presence of influenza peptides
derivatized with a crosslinking reagent and iodinated. Their binding
will then be assessed, subsequent to crosslinking induced by U.V. light
exposure, through immunoprecipitation with anti-class II antibodies,
electrophoresis, and autoradiography. Alternatively, binding can be
examined through gel filtration to separate bound from free peptides.
The answers derived from these studies will serve a dual role: (a)
enhance our understanding of a fundamental question in immunology and (b)
identify a region in Ii which might serve as a backbone in the synthesis
of peptide-based vaccines.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4049/jimmunol.157.6.2506
发表时间:
1996-09
期刊:
Journal of immunology
影响因子:
4.4
作者:
[R. Garofalo;Fang C Mei;R. Espejo;Gang Ye;Helene A. Haeberle;Samuel Baron;P. Ogra;Victor E. Reyes]
通讯作者:
R. Garofalo;Fang C Mei;R. Espejo;Gang Ye;Helene A. Haeberle;Samuel Baron;P. Ogra;Victor E. Reyes
Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection.
人胃上皮细胞表达 B7-1 和 B7-2 共刺激分子:幽门螺杆菌感染期间 CD4 T 细胞激活的潜在作用。
DOI:
10.1172/jci119325
发表时间:
1997
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Ye,G, Barrera,C, Fan,X, Gourley,WK, Crowe,SE, Ernst,PB, Reyes,VE]
通讯作者:
Reyes,VE
Expression of cathepsins B, L, S, and D by gastric epithelial cells implicates them as antigen presenting cells in local immune responses.
胃上皮细胞表达组织蛋白酶 B、L、S 和 D,表明它们在局部免疫反应中作为抗原呈递细胞。
DOI:
10.1016/s0198-8859(01)00281-6
发表时间:
2001
期刊:
Human immunology
影响因子:
2.7
作者:
[Barrera,C, Ye,G, Espejo,R, Gunasena,S, Almanza,R, Leary,J, Crowe,S, Ernst,P, Reyes,VE]
通讯作者:
Reyes,VE
Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern.
组织蛋白酶 B 的裂解和 MHC II 类分子中不变链的释放遵循分阶段的模式。
DOI:
10.1016/0161-5890(94)90146-5
发表时间:
1994
期刊:
Molecular immunology
影响因子:
3.6
作者:
[Xu,M, Capraro,GA, Daibata,M, Reyes,VE, Humphreys,RE]
通讯作者:
Humphreys,RE
Invariant chain dissociation from class II MHC is a catalyst for foreign peptide binding.
II 类 MHC 的不变链解离是外源肽结合的催化剂。
DOI:
10.1111/j.1749-6632.1994.tb44285.x
发表时间:
1994
期刊:
Annals of the New York Academy of Sciences
影响因子:
5.2
作者:
[Reyes,VE, Daibata,M, Espejo,R, Humphreys,RE]
通讯作者:
Humphreys,RE
Colonic myofibroblast activation of PD-1 pathways in inflammatory bowel diseases
-
批准号:8097751
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2010
-
负责人:VICTOR E. REYES
-
依托单位:
Immune Evasion by H. pylori
-
批准号:8145789
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2010
-
负责人:VICTOR E. REYES
-
依托单位:
Protein Biomarkers of Gastric Cancer
-
批准号:7589971
-
项目类别:
-
资助金额:$19.93万
-
财政年份:2009
-
负责人:VICTOR E. REYES
-
依托单位:
Protein Biomarkers of Gastric Cancer
-
批准号:7844854
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2009
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2151710
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6177482
-
项目类别:
-
资助金额:$25.26万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6604093
-
项目类别:
-
资助金额:$27.6万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6381031
-
项目类别:
-
资助金额:$26.02万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2430253
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2151711
-
项目类别:
-
资助金额:$29.64万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:6517381
-
项目类别:
-
资助金额:$26.8万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
-
批准号:2758342
-
项目类别:
-
资助金额:$24.12万
-
财政年份:1995
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:3456373
-
项目类别:
-
资助金额:$10.33万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:3456372
-
项目类别:
-
资助金额:$9.98万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
ROLE OF Ii CLEAVAGE AND RELEASE IN ANTIGEN PRESENTATION
-
批准号:2069128
-
项目类别:
-
资助金额:$10.5万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位:
Ii CLEAVAGE AND RELEASE AND ANTIGEN PRESENTATION
-
批准号:2069127
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1992
-
负责人:VICTOR E. REYES
-
依托单位: